[go: up one dir, main page]

KR100890462B1 - Pediococcus spissis JNU44 - Google Patents

Pediococcus spissis JNU44 Download PDF

Info

Publication number
KR100890462B1
KR100890462B1 KR1020070060639A KR20070060639A KR100890462B1 KR 100890462 B1 KR100890462 B1 KR 100890462B1 KR 1020070060639 A KR1020070060639 A KR 1020070060639A KR 20070060639 A KR20070060639 A KR 20070060639A KR 100890462 B1 KR100890462 B1 KR 100890462B1
Authority
KR
South Korea
Prior art keywords
lactobacillus
pediococcus
jnu534
spissis
kccm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020070060639A
Other languages
Korean (ko)
Other versions
KR20080111990A (en
Inventor
오세종
진구복
Original Assignee
전남대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 전남대학교산학협력단 filed Critical 전남대학교산학협력단
Priority to KR1020070060639A priority Critical patent/KR100890462B1/en
Publication of KR20080111990A publication Critical patent/KR20080111990A/en
Application granted granted Critical
Publication of KR100890462B1 publication Critical patent/KR100890462B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/70Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729Organic compounds; Microorganisms; Enzymes
    • A23B2/7295Antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/70Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729Organic compounds; Microorganisms; Enzymes
    • A23B2/783Microorganisms; Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

본 발명은 원유, 발효유, 김치, 사람의 분변 및 가축의 분변으로부터 분리하며, 유해성 미생물 또는 식품을 변패를 일으키는 미생물의 생육을 억제하는 기능을 갖는 페디오코쿠스 스피시스 JNU534(기탁기관 : 한국종균협회부설 한국미생물보존센터, 수탁번호 : KCCM-10869P호, 수탁일자 : 2007년 5월 2일)에 관한 것으로 상기 페디오코쿠스 스피시스 JNU534 또는 그 배양물을 이용하여 천연방부제, 식품 조성물, 사료용 조성물 및 항균 조성물 등에 광범위하게 사용될 수 있는 페디오코쿠스 스피시스 JNU534에 관한 것이다.The present invention is isolated from crude oil, fermented milk, kimchi, human feces and livestock feces, and has a function of inhibiting the growth of harmful microorganisms or food-causing microorganisms causing decay pediococcus spissis JNU534 (deposit institution: Korea spawn association The Korea Microorganisms Preservation Center, Accession No .: KCCM-10869P, Accession Date: May 2, 2007), using the Pediococcus spissis JNU534 or its cultures, the natural preservative, food composition, feed composition and It relates to Pediococcus spissis JNU534 that can be widely used in antimicrobial compositions and the like.

페디오코쿠스 스피시스, 항균작용, 박테리오신 Pediococcus spice, antibacterial activity, bacteriocin

Description

페디오코쿠스 스피시스 JNU534{PEDIOCOCCUS DAMNOSUS JNU534}Pediococcus spissis JNJ44 {PEDIOCOCCUS DAMNOSUS JNU534}

도 1은 본 발명의 페디오코쿠스 스피시스 JNU534의 옥틸-세파로스 칼럼크로마토그래피로 분별한 결과를 나타내는 그래프이다.1 is a graph showing the results of fractionation by octyl-sepharose column chromatography of pediococcus spissis JNU534 of the present invention.

도 2는 본 발명의 페디오코쿠스 스피시스 JNU534가 생산하는 박테리오신의 열처리시 활성 변화를 나타내는 그래프이다.Figure 2 is a graph showing the change in activity during the heat treatment of the bacteriocin produced by Pediococcus spissis JNU534 of the present invention.

도 3은 본 발명의 페디오코쿠스 스피시스 JNU534가 생산하는 박테리오신의 효소처리에 의한 박테리오신의 활성 변화를 나타내는 그래프이다.Figure 3 is a graph showing the change in activity of bacteriocin by the enzyme treatment of bacteriocin produced by Pediococcus spissis JNU534 of the present invention.

본 발명은 페디오코쿠스 스피시스(Pediococcus Damnosus) JNU534에 관한 것으로, 보다 자세하게는 김치로부터 분리하며, 병원성 또는 부패성 등의 유해성 미생물의 생육을 억제하는 기능이 있어 천연방부제, 식품 조성물, 사료용 조성물 및 항균 조성물 등에 광범위하게 사용될 수 있는 페디오코쿠스 스피시스 JNU534에 관한 것이다.The present invention relates to Pediococcus spissis (Pediococcus Damnosus) JNU534, more specifically, it is separated from kimchi, and has the function of inhibiting the growth of harmful microorganisms, such as pathogenic or decaying, natural preservatives, food compositions, feed compositions and antibacterial It relates to a Pediococcus spissis JNU534 that can be widely used in compositions and the like.

유산균들은 다양한 발효식품의 생산과 저장성 향상 및 사람을 포함한 각종 동물의 장내에 서식하여 미생물총을 조절하고 건강을 증진시키는 등의 중요한 역할을 담당한다.Lactic acid bacteria play an important role in improving the production and storage of various fermented foods and inhabiting the intestines of various animals including humans to control microorganisms and improve health.

특히 상기 유산균이 생산하는 항미생물성 물질 중 박테리오신은 천연 단백질성 물질로 유전적 조작을 통해 생산이 조절될 수 있고 다양한 식품 내 존재하는 병원성 및 부패성 균들의 성장을 억제할 수 있어 박테리오신을 이용한 천연 식품 보존제 개발에 관련된 연구들이 점차 증가되고 있는 추세이다. Especially, among the antimicrobial substances produced by the lactic acid bacteria, bacteriocin is a natural proteinaceous substance, which can be controlled through genetic manipulation and inhibits the growth of pathogenic and decaying bacteria present in various foods. There is an increasing number of studies related to the development of preservatives.

최근 들어 소비자들은 식품의 안전성에 관심이 매우 크며, 인공적인 방부제나 식품첨가물이 적게 들어가거나 전혀 첨가되지 않은 자연식품을 선호하고 있다.  Recently, consumers are very concerned about food safety and prefer natural foods with little or no artificial preservatives or food additives.

따라서 화학물질인 방부제나 식품첨가물의 사용을 줄일 수 있는 방법이 시급히 요구되고 있다.Therefore, there is an urgent need for a method of reducing the use of chemical preservatives or food additives.

상기 박테리오신은 미생물이 생산하는 천연의 무독성 방부제로 주목받고 있는 항균성 단백질이며 인체에 섭취되며 소화기관의 단백질 가수 분해 효소에 의해 분해됨으로써, 인체에 무독하고 잔류성이 없다는 점에서 식품 등의 천연 방부제로서의 효용성이 증대되고 있다. The bacteriocin is an antimicrobial protein that is attracting attention as a natural nontoxic preservative produced by microorganisms, and is ingested by the human body and degraded by proteolytic enzymes of the digestive organs, so that it is toxic to humans and has no residual effect. Is increasing.

상기 박테리오신은 또한 비교적 고온에서 불활성화되지 않으며, 광범위한 pH에서 안정성을 갖는 것이 특징이고 무독, 무색, 무취이므로 화학 합성 방부제를 대체할 수 있는 광범위한 용도 개발이 기대된다.The bacteriocins are also inert at relatively high temperatures, are characterized by stability at a wide range of pH, and are toxic, colorless, and odorless, and thus are expected to develop a wide range of applications that can replace chemical synthetic preservatives.

즉, 발효유, 발효 알콜 음료, 통조림, 냉장·냉동제품에서의 저장성 향상 외 에도 고추장, 된장, 두부, 유산균 발효제품 등의 저장성 연장 및 김치, 약주, 탁주 등 전통식품의 산패 및 변질 방지, 어패류의 신선도 유지와 콩나물 등 과실 및 야채류의 저장성을 향상시킬 수 있다.In other words, in addition to improving shelf life in fermented milk, fermented alcoholic beverages, canned food, and refrigerated and frozen products, it extends the shelf life of fermented products such as red pepper paste, soybean paste, tofu, and lactic acid bacteria, and prevents rancidity and deterioration of traditional foods such as kimchi, medicinal wine, and takju. It can improve freshness and shelf life of fruits and vegetables such as bean sprouts.

본 발명의 발명자들은 김치로부터 분리하여 새로운 유산균을 얻는데 성공하였다.The inventors of the present invention succeeded in obtaining new lactic acid bacteria by separating from kimchi.

따라서, 본 발명은 상기와 같은 종래 기술의 제반 단점과 문제점을 해결하기 위한 것으로, 김치로부터 분리하며, 유해성 미생물 또는 식품을 변패를 일으키는 미생물의 생육을 억제하는 기능을 갖는 페디오코쿠스 스피시스 JNU534 또는 그 배양물을 이용하여 천연방부제, 식품 조성물, 사료용 조성물 및 항균 조성물 등에 광범위하게 사용될 수 있는 페디오코쿠스 스피시스 JNU534를 제공함에 본 발명의 목적이 있다.Accordingly, the present invention is to solve the above-mentioned disadvantages and problems of the prior art, it is separated from kimchi, pediococcus spissis JNU534 or has the function of inhibiting the growth of harmful microorganisms or microorganisms causing decay It is an object of the present invention to provide a Pediococcus spissis JNU534 that can be widely used in natural preservatives, food compositions, feed compositions and antimicrobial compositions using the culture.

본 발명의 상기 목적은 유해성 미생물 또는 식품을 변패를 일으키는 미생물의 생육을 억제하는 기능을 갖는 페디오코쿠스 스피시스 JNU534(기탁기관 : 한국종균협회부설 한국미생물보존센터, 수탁번호 : KCCM-10869P호, 수탁일자 : 2007년 5월 2일)에 의해 달성된다.The above object of the present invention has a function of inhibiting the growth of harmful microorganisms or microorganisms that cause deterioration of foods Pediococcus spissis JNU534 (deposit institution: Korea Microbiological Conservation Center affiliated with Korea spawn association, Accession No .: KCCM-10869P, Date of Deposit: May 2, 2007).

또한, 본 발명의 상기 목적은 상기 페디오코쿠스 스피시스 JNU534가 김치로 부터 분리 가능한 것을 특징으로 하는 페디오코쿠스 스피시스 JNU534에 의해서도 달성된다.In addition, the above object of the present invention is also achieved by the Pediococcus spissis JNU534, characterized in that the Pediococcus spissis JNU534 is separable from kimchi.

또한, 본 발명의 상기 목적은 상기 유해성 미생물 또는 식품을 변패를 일으키는 미생물이 리스테리아 모노시토제네스, 리스테리아 모노시토제네스 KCTC 3569, 스타필로코커스 오레우스, 락토바실러스 플란타럼 KCCM 11322, 락토바실러스 플란타럼 L155, 락토바실러스 플란타럼 L165, 락토바실러스 플란타럼 L167, 락토바실러스 애시도필러스 NOCKS, 락토바실러스 애시도필러스 KCCM 32820, 락토바실러스 애시도필러스 CH5, 락토바실러스 애시도필러스 GP1B, 락토바실러스 가세리 KCTC 3163, 락토바실러스 크리스파터스 KCCM 41620, 락토바실러스 브레비스 KCCM 35464, 락토바실러스 카제이 YIT 9029, 락토바실러스 카제이 Y1, 락토바실러스 람노수스 GG 및 류코노스톡 메센테로이데스 KCCM 35471 중 어느 하나 이상인 것을 특징으로 하는 페디오코쿠스 스피시스 JNU534에 의해서도 달성된다.In addition, the object of the present invention is that the harmful microorganisms or microorganisms that cause the food to deteriorate Listeria monocytogenes, Listeria monocytogenes KCTC 3569, Staphylococcus aureus, Lactobacillus plantarum KCCM 11322, Lactobacillus plantarum L155, Lactobacillus plantarum L165, Lactobacillus plantarum L167, Lactobacillus ashdophyllus NOCKS, Lactobacillus ashdophilus KCCM 32820, Lactobacillus ashdophyllus CH5, Lactobacillus ashdophilus GP1B, Lactobacillus Bacillus gasser KCTC 3163, Lactobacillus crispatus KCCM 41620, Lactobacillus brevis KCCM 35464, Lactobacillus cascai YIT 9029, Lactobacillus cascai Y1, Lactobacillus rhamnosus GG and Lyukonostock mesenteroides KCCM 35471 It is achieved by pediococcus spice CIS JNU534 characterized by the above .

또한, 본 발명의 상기 목적은 상기 페디오코쿠스 스피시스 JNU534으로부터 생산된 박테리오신이 3.4kDa의 분자량을 갖는 것을 특징으로 하는 페디오코쿠스 스피시스 JNU534에 의해서도 달성된다.In addition, the above object of the present invention is also achieved by Pediococcus spissis JNU534, characterized in that the bacteriocin produced from the Pediococcus spisus JNU534 has a molecular weight of 3.4kDa.

또한, 본 발명의 상기 목적은 상기 페디오코쿠스 스피시스 JNU534으로부터 생산된 박테리오신의 최초 8개의 아미노산 서열은 NH2-Ile-Leu-Leu-Glu-Glu-Leu-Asn-Val인 것을 특징으로 하는 페디오코쿠스 스피시스 JNU534에 의해서도 달성된다.In addition, the above object of the present invention is a pedi, characterized in that the first eight amino acid sequence of the bacteriocin produced from the Pediococcus spissis JNU534 is NH 2 -Ile-Leu-Leu-Glu-Glu-Leu-Asn-Val It is also achieved by Okoccus Spissis JNU534.

또한, 본 발명의 상기 목적은 상기 페디오코쿠스 스피시스 JNU534 또는 그 배양물을 포함하는 천연방부제, 식품 조성물, 사료용 조성물 및 항균 조성물에 의해서도 달성된다.In addition, the above object of the present invention is also achieved by the natural preservative, food composition, feed composition and antimicrobial composition comprising the Pediococcus spissis JNU534 or its culture.

본 발명의 상기 목적과 기술적 구성 및 그에 따른 작용효과에 관한 자세한 사항은 본 발명의 바람직한 실시 예를 도시하고 있는 도면을 참조한 이하 상세한 설명에 의해보다 명확하게 이해될 것이다.Details of the above object, technical configuration and effects according to the present invention will be more clearly understood by the following detailed description with reference to the drawings showing preferred embodiments of the present invention.

1. 항균물질 생산 유산균의 선발 및 배양 조건1. Selection and Culture Conditions of Lactic Acid Bacteria Producing Antibacterial Substances

본 발명의 페디오코쿠스 스피시스 JNU534(기탁기관 : 한국종균협회부설 한국미생물보존센터, 수탁번호 : KCCM-10869P호, 수탁일자 : 2007년 5월 2일)는 김치로부터 분리한 유산균 균주들을 MRS 배지(broth)(Difco, USA)에 접종하고 37℃에서 2회 계대 배양하여 항균활성 측정에 사용하였다. 지시균으로 사용한 유산균은 MRS 배양액에 그람(Gram)(+) 및 그람(-)의 병원성 균을 TS 배지(tryptic soy broth)(Difco, USA)에 접종하여 같은 조건으로 배양하였다.Pediococcus spissis JNU534 of the present invention (depositary organization: Korea Microbiological Conservation Center affiliated with the Korean spawn association, Accession No .: KCCM-10869P, date of deposit: May 2, 2007) is the MRS medium from the lactic acid bacteria strains isolated from kimchi (broth) (Difco, USA) and incubated twice at 37 ℃ was used for antimicrobial activity measurement. The lactic acid bacteria used as indicator bacteria were inoculated in Gram (+) and Gram (-) pathogenic bacteria in TS medium (tryptic soy broth) (Difco, USA) and cultured under the same conditions.

표 1은 상기 MRS 배지 1L의 조성을 나타내고, 표 2는 상기 TS 배지 1L의 조성을 나타내고 있다.Table 1 shows the composition of 1L of the MRS medium, and Table 2 shows the composition of the 1L of TS medium.

박토 프로테오스 펍톤Bacto Proteos Pubton 10g10 g 박토 비프 엑기스Bakto Beef Extract 10g10 g 박토 이스트 엑기스Bacto East Extract 5g5 g 텍스트로스Text Ross 20g20 g 폴리소르베이트BD(or Twwep BD)Polysorbate BD (or Twwep BD) 1g1 g 암모니움 시트레이트Ammonium citrate 2g2 g 소튬 아세테이트Sodium acetate 5g5 g 황산마그네슘Magnesium sulfate 0.1g0.1g 황산화망간Manganese Sulfate 0.05g0.05g 인산화제이칼륨Dipotassium Phosphate 2g2 g

박토 트립톤Bacto trypton 17g17 g 박토 소이톤Bakto Soyton 3g3 g 텍스트로스Text Ross 2.5g2.5g 염화나트륨Sodium chloride 5g5 g 인산화제이칼륨Dipotassium Phosphate 2.5g2.5g

2. 박테리오신 생산 균주의 선발 및 동정2. Selection and Identification of Bacteriocin Producing Strains

박테리오신 생산균주의 선발은 한천 확산법(agar-well diffusion method)을 이용하여 수행하였다. Selection of the bacteriocin producing strain was performed using the agar-well diffusion method.

즉, 각 유산균을 MRS 배지에 접종하여 37℃에서 18시간 동안 배양하고 원심분리(13,000rpm, 10min, 4℃)하여 상등액을 회수하였다.That is, the lactic acid bacteria were inoculated in MRS medium, incubated at 37 ° C. for 18 hours, and centrifuged (13,000 rpm, 10 min, 4 ° C.) to recover the supernatant.

이를 각각 pH4.5 및 pH6.5로 조정한 후, 0.45 ㎛-공극 사이즈 멤브레인 필터(pore size membrane filter)(Advantec MFS, USA)로 여과하여 박테리오신 활성을 확인하기 위한 시료로 사용하였다.This was adjusted to pH4.5 and pH6.5, respectively, and then filtered through a 0.45 μm-pore size membrane filter (Advantec MFS, USA) to be used as a sample for confirming bacteriocin activity.

세균 배양 접시(Petri dish)에 멸균된 메탈 보어(metal borer)를 놓은 후 약 15ml의 MRS 고체 배지를 분주하여 굳히고 그 위에 지시균인 포도상구균(Staphylococcus aureus)를 1% 농도로 접종한 TSSA(tryptic soy soft agar)(0.85%)를 중층하여 굳혔다. After placing a sterile metal borer in a petri dish, an aliquot of about 15 ml of MRS solid medium was dispensed and hardened, and TSSA (tryptic) inoculated with 1% concentration of Staphylococcus aureus. soy soft agar) (0.85%) layered and hardened.

상기 메탈 보어를 제거하여 만들어진 웰(well)에 각 균주의 배양 상등액을 180㎕씩 분주하고 37℃에서 18시간 동안 배양한 후 나타나는 억제환의 크기를 통해 지시균의 생육 억제 여부를 관찰하여 박테리오신 활성을 확인하였다.The culture supernatant of each strain was dispensed in a well prepared by removing the metal bore, and the culture supernatant of each strain was dispensed and cultured for 18 hours at 37 ° C. Confirmed.

상기와 같은 방법으로 최종적으로 선발된 유산균은 그람 염색법(Gram stain)을 통해 형태학적 특징을 확인하고 API 50CH 탄수화물 검사 키트(carbohydrate test kit)(Bio Merieux, France)를 이용한 당발효성을 조사하여 ATB 아이데틴피케이션 프로그램(identification program)(Bio Merieux, France)에 입력한 결과를 바탕으로 동정한 결과 본 발명의 페디오코쿠스 스피시스 JNU534와 96.8%의 상동성을 나타냈었다.The lactic acid bacteria finally selected by the above method were confirmed morphological characteristics by Gram staining and ATB by examining sugar fermentation using API 50CH carbohydrate test kit (Bio Merieux, France). As a result of the identification on the basis of the results entered into the identification program (Bio Merieux, France), 96.8% homology with the Pediococcus spissis JNU534 of the present invention was shown.

상기 분석 결과인 당발효 시험결과를 표 3에 정리하였다.The sugar fermentation test results, the analysis results are summarized in Table 3.

No.No. 당 기질Sugar substrate 성장여부Growth No.No. 당 기질Sugar substrate 성장여부Growth 00 ControlControl -- 2525 EsculinEsulin ++ 1One GlycerolGlycerol -- 2626 SalicinSalicin ++ 22 ErythritolErythritol -- 2727 CellobioseCellobiose ++ 33 D-ArabinoseD-Arabinose -- 2828 MaltoseMaltose -- 44 L-ArabinoseL-Arabinose -- 2929 LactoseLactose -- 55 RiboseRibose -- 3030 MelibioseMelibiose -- 66 D-XyloseD-Xylose -- 3131 SucroseSucrose -- 77 L-XyloseL-Xylose -- 3232 TrehaloseTrehalose -- 88 AdonitolAdonitol -- 3333 InulinInulin -- 99 β-Methyl-D-xylosideβ-Methyl-D-xyloside -- 3434 MelezitoseMelezitose -- 1010 GalacotoseGalacotose ++ 3535 RaffinoseRaffinose -- 1111 GlucoseGlucose ++ 3636 StarchStarch -- 1212 FructoseFructose ++ 3737 GlycogenGlycogen -- 1313 ManoseManose ++ 3838 XylitolXylitol -- 1414 SorboseSorbose -- 3939 GentiobioseGentiobiose -- 1515 RhamnoseRhamnose -- 4040 D-TuranoseD-Turanose -- 1616 DulcitolDulcitol -- 4141 D-LyxoseD-Lyxose -- 1717 InositolInositol -- 4242 D-TagatoseD-Tagatose -- 1818 MannitolMannitol -- 4343 D-FucoseD-Fucose -- 1919 SorbitolSorbitol -- 4444 L-FucoseL-Fucose -- 2020 α-Methyl-D-mannosideα-Methyl-D-mannoside -- 4545 D-ArabitolD-Arabitol -- 2121 α-Methyl-D-glucosideα-Methyl-D-glucoside -- 4646 L-ArabitolL-Arabitol -- 2222 N-Acetyl glucosamineN-Acetyl glucosamine -- 4747 GluconateGluconate -- 2323 AmygdalinAmygdalin -- 4848 2-keto-gluconate2-keto-gluconate -- 2424 ArbutinArbutin -- 4949 5-keto-gluconate5-keto-gluconate --

+ : 성장, - : 성장하지 않음 +: Growing,-: not growing

3. 배양시간별 세포의 생장 및 박테리오신 생산3. Cell Growth and Bacteriocin Production by Culture Time

박테리오신을 생산하는 유산균을 106 CFU/ml 농도로 MRS 배지에 접종한 후 37℃에서 48시간 동안 배양하면서 3시간 간격으로 생균수와 pH를 측정하였다.The bacteriocin-producing lactic acid bacteria were inoculated in MRS medium at a concentration of 10 6 CFU / ml, followed by incubation at 37 ° C. for 48 hours, and the number of viable cells and pH were measured at 3 hour intervals.

또한 각 시간대의 배양액을 상기 방법과 동일하게 처리하여 얻은 상등액을 이용하여 임계 희석법(critical dilution method)(Hoover and Harlander, 1993)에 의해 박테리오신 활성의 변화를 측정하였다.In addition, the change of bacteriocin activity was measured by the critical dilution method (Hoover and Harlander, 1993) using the supernatant obtained by treating the culture solution in each time zone in the same manner as the above method.

즉, MRS 배지 위에 멸균 증류수로 연속 2진 희석(two-fold dilution)한 상등액을 점적하고 지시균인 락토바실루스 플란티룸(Lactobacillus plantarum)이 접종된 MRS 소프트 배지를 중층하여 37℃에서 18시간 동안 배양한 후 억제환을 확인하였다.That is, a supernatant of two-fold dilution with sterile distilled water was dropped on the MRS medium, and the MRS soft medium inoculated with Lactobacillus plantarum, which is an indicator bacterium, was incubated at 37 ° C. for 18 hours. After the suppression was confirmed.

하기의 표 4는 상기 선발 박테리오신의 항균 활성을 나타내는 것으로 상기에서 동정된 균주를 이용하여 11종의 병원성 균과 19종의 유산균에 대한 생육 저해활성을 평가한 결과를 나타낸 것이다.Table 4 below shows the antimicrobial activity of the selected bacteriocin and shows the results of evaluating the growth inhibitory activity against 11 pathogenic bacteria and 19 lactic acid bacteria using the strains identified above.

지시균(Indicator strains)Indicator strains 저해여부(Inhibition)Inhibition Listeria monocytogenes Listeria monocytogenes ++ Listeria monocytogenes KCTC 3569 Listeria monocytogenes KCTC 3569 ++ Listeria ivanovii Listeria ivanovii -- Listeria innocua Listeria innocua -- Staphylococcus aureus Staphylococcus aureus ++ E. coli O0157:H7 ATCC 43889 E. coli O0157: H7 ATCC 43889 -- E. coli O0157:H7 ATCC 43894 E. coli O0157: H7 ATCC 43894 -- E. coli O0157:H7 ATCC 43895 E. coli O0157: H7 ATCC 43895 -- Salmonella typhimurium Salmonella typhimurium -- Klebsisella pneumoniase Klebsisella pneumoniase -- Enterobacter aerogenes Enterobacter aerogenes -- Lactobacillus plantarum L167 Lactobacillus plantarum L167 ++ Lactobacillus acidophilus NOCKS Lactobacillus acidophilus NOCKS ++ Lactobacillus plantarum L165 Lactobacillus plantarum L165 ++ Lactobacillus helveticus CH1 Lactobacillus helveticus CH1 -- Lactobacillus gasseri KCTC 3163 Lactobacillus gasseri KCTC 3163 ++ Lactobacillus acidophilus KCCM 32820 Lactobacillus acidophilus KCCM 32820 ++ Lactobacillus acidophilus CH5 Lactobacillus acidophilus CH5 ++ Lactobacillus crispatus KCCM 41620 Lactobacillus crispatus KCCM 41620 ++ Lactobacillus brevis KCCM 35464 Lactobacillus brevis KCCM 35464 ++ Lactobacillus plantarum L155 Lactobacillus plantarum L155 ++ Lactobacillus acidophilus GP1B Lactobacillus acidophilus GP1B ++ Lactobacillus plantarum KCCM 11322 Lactobacillus plantarum KCCM 11322 ++ Lactobacillus casei YIT9029 Lactobacillus casei YIT9029 ++ Lactobacillus rhamnosus GG Lactobacillus rhamnosus GG ++ Lactobacillus paracasei ssp. paracasei P113 Lactobacillus paracasei ssp. paracasei P113 -- Lactobacillus casei Y1 Lactobacillus casei Y1 ++ Lactococcus lactis KCCM 40104 Lactococcus lactis KCCM 40104 -- Leuconostoc mesenteroides KCCM 35471 Leuconostoc mesenteroides KCCM 35471 ++ Pediococcus pentosaceus KCCM 40464 Pediococcus pentosaceus KCCM 40464 --

+ : 억제됨, - : 억제되지 않음.+: Suppressed,-: not suppressed.

상기 표 4에서 보는 바와 같이 리스테리아 모노시토제네스(Listeria monoctogenes), 리스테리아 모노시토제네스(Listeria monoctogenes) KCTC 3569, 스타필로코커스 오레우스(staphylococcus aureus), 락토바실러스 플란타럼(Lactobacillus plantarum) KCCM 11322, 락토바실러스 플란타럼(Lactobacillus plantarum) L155, 락토바실러스 플란타럼(Lactobacillus plantarum) L165 락토바실러스 플란타럼(Lactobacillus plantarum) L167, 락토바실러스 애시도필러스(Lactobacillus acidophilus) NOCKS, 락토바실러스 애시도필러스(Lactobacillus acidophilus) KCCM 32820, 락토바실러스 애시도필러스(Lactobacillus acidophilus) CH5, 락토바실러스 애시도필러스(Lactobacillus acidophilus) GP1B, 락토바실러스 가세리(Lactobacillus gasseri) KCTC 3163, 락토바실러스 크리스파터스(Lactobacillus crispatus) KCCM 41620, 락토바실러스 브레비스(Lactobacillus brevis) KCCM 35464, 락토바실러스 카제이(Lactobacillus casei) YIT 9029, 락토바실러스 카제이(Lactobacillus casei) Y1, 락토바실러스 람노수스(Lactobacillus rhamnosus) GG 및 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) KCCM 35471 등에 대해서는 항균활성을 나타내고 있으나 대장균(E. coli), 장티프스균(Salmonella typhimurium), 크렙시엘라 뉴모니에(Klebsiella pneumoniae), 엔테로박터 에어로제너스(Enterobacter aerogenes) 등 그람(-)균의 생육은 저해하지 못했다.As shown in Table 4, Listeria monoctogenes, Listeria monoctogenes KCTC 3569, Staphylococcus aureus, Lactobacillus plantarum KCCM 11322, Lactobacillus Lactobacillus plantarum L155, Lactobacillus plantarum L165 Lactobacillus plantarum L167, Lactobacillus acidophilus NOCKS, Lactobacillus ashdophyllus Lactobacillus acidophilus KCCM 32820, Lactobacillus acidophilus CH5, Lactobacillus acidophilus GP1B, Lactobacillus gasseri KCTC 3163, Lactobacillus crispapatus crispatus KCCM 41620, Lactobacillus brevis KCCM 35464, Lactobacillus Lactobacillus casei YIT 9029, Lactobacillus casei Y1, Lactobacillus rhamnosus GG, and Leuconostoc mesenteroides KCCM 35471 show antibacterial activity (E. coli), Salmonella typhimurium, Klebsiella pneumoniae, Enterobacter aerogenes, etc. did not inhibit the growth of gram (-) bacteria.

4. 박테리오신의 정제4. Purification of Bacteriocin

본 발명의 페디오코쿠스 스피시스 JNU534를 2회 계대 배양한 후, MRS 배지 1,000ml에 1%농도로 접종하여 18시간 배양한 후 원심분리(8,000rpm, 30min, 4℃)하여 상등액을 회수하였다.After two passages of Pediococcus spissis JNU534 of the present invention, the supernatant was recovered by centrifugation (8,000rpm, 30min, 4 ° C) after incubating for 18 hours by inoculating 1% concentration in 1,000 ml of MRS medium.

상기 배양 상등액에 황산암모늄(ammonium sulfate)을 30% 농도로 첨가하면서 12시간 이상 4℃에서 서서히 교반시킨 후 다시 원심분리(8,000rpm, 30min, 4℃)하였다.Ammonium sulfate was added to the culture supernatant at a concentration of 30% and stirred slowly at 4 ° C. for at least 12 hours, followed by centrifugation (8,000 rpm, 30 min, 4 ° C.).

여기서 얻어진 침전물을 50mM MES(2-(4-morpholino)-ethane sulfonic acid)(Sigma, USA) 버퍼(pH 7.0) 50ml에 용해시켜 제조한 조박테리오신(crude bacteriocin) 용액을 -20℃에 보관하며 사용하였다. A crude bacteriocin solution prepared by dissolving the precipitate obtained in 50 ml of 50 mM MES (2- (4-morpholino) -ethane sulfonic acid) (Sigma, USA) buffer (pH 7.0) was stored at -20 ° C. It was.

1.7M 황산암모늄의 3 베드 용적(bed volume)으로 평형화된 옥틸-세파로스 CL-4B 컬럼(Octyl-Sepharose CL-4B column)(Bio-rad, USA)에 조박테리오신 용액을 주입하여 크로마토그래피(chromatography)를 실시하였다.Chromatography was performed by injecting a Zobacteriocin solution into an Octyl-Sepharose CL-4B column (Bio-rad, USA) equilibrated to a three bed volume of 1.7 M ammonium sulfate. ) Was performed.

상기 조박테리오신 용액을 이용하여 수소성결합 컬럼 크로마토그래피(hydrophobic interaction coumn chromatography)를 실시한 결과를 도 1에 도시하고 있는데, 총 78개의 분획 중에서 6개의 박테리오신 활성 분획을 분리하였으며 이중에서 214nm에서의 흡광도 측정 결과 나타난 피크(peak)와 일치하며 가장 높은 박테리오신 활성(400 AU/ml)을 보이는 분획을 전기영동 시료로 사용하였다. Hydrophobic interaction column chromatography using the crude bacteriocin solution is shown in FIG. 1. Six bacteriocin active fractions were isolated from a total of 78 fractions, and the absorbance at 214 nm was measured. Fractions consistent with the resulting peak and showing the highest bacteriocin activity (400 AU / ml) were used as electrophoretic samples.

이를 통해 얻은 분획에 대하여 214nm에서의 흡광도를 측정하고 지시균에 대한 항균물질 생산 여부를 확인한 후 항균활성을 나타낸 분획만을 회수하여 각각의 박테리오신 활성을 측정하였다.The absorbance at 214nm was measured for the fractions obtained, and after confirming the production of antimicrobial substances against indicator bacteria, only the fractions showing the antimicrobial activity were recovered and the respective bacteriocin activities were measured.

가장 높은 박테리오신 활성을 보인 분획을 -70℃에서 동결시킨 뒤 건조, 농축하고 2×트리신-SDS 샘플 버퍼(tricine-SDS sample buffer)(Novex, USA)에 용해시켜 전기영동 시료로 사용하였다.Fractions showing the highest bacteriocin activity were frozen at −70 ° C., dried, concentrated, dissolved in 2 × tricine-SDS sample buffer (Novex, USA) and used as electrophoretic samples.

상기 전기영동은 4%의 스택킹 겔(stacking gel), 10%의 스페이서 겔(spacer gel) 및 16%의 세퍼레이팅 겔(separaging gel)을 제조하여 미니-프로티안 3셀(Mini-PROTEAN 3cell)(Bio-Rad, USA)을 사용하여 125V의 일정한 전압으로 60분 동안 트리신-SDS-페이지(Tricine-SDS-PAGE)(Schagger and Von Jagow, 1987)를 실시하였다.The electrophoresis was performed by preparing a 4% stacking gel, a 10% spacer gel, and a 16% separation gel to produce a mini-PROTEAN 3cell. Tri-SDS-PAGE (Schagger and Von Jagow, 1987) was performed for 60 minutes at a constant voltage of 125 V using (Bio-Rad, USA).

상기 전기영동이 완료된 겔은 미니 트랜스-볼트 셀(Mini Trans-Blot Cell)(Bio-Rad, USA)을 이용하여 4℃에서 50V의 일정한 전압으로 3시간 동안 PVDF(polyvinylidene difluoride) 멤브레인에 블로팅(blotting)하였다. The electrophoresis-completed gel was blotted onto a polyvinylidene difluoride (PVDF) membrane for 3 hours at a constant voltage of 50 V at 4 ° C. using a Mini Trans-Blot Cell (Bio-Rad, USA). blotting).

상기 압지가 완료된 멤브레인을 에드만 분해(Edman degradation)에 의한 N-터미널 서열 결정(N-terminal sequencing)을 실시하였다.N-terminal sequencing was performed by Edman degradation of the bloated membrane.

상기 에드만 분해에 의해 아미노산 서열을 분석한 결과 최초의 8개 아미노산만 NH2-Ile-Leu-Leu-Glu-Glu-Leu-Asn-Val로 판독되었으며 9번째 서열부터는 블록킹(blocking)되어 분석하지 못하였다.As a result of analyzing the amino acid sequence by Edman digestion, only the first 8 amino acids were read as NH 2 -Ile-Leu-Leu-Glu-Glu-Leu-Asn-Val, and from the ninth sequence, blocking was not performed. I couldn't.

5. 박테리오신의 특성5. Characteristics of Bacteriocin

회수한 상등액을 5N NaOH를 이용하여 pH 6.5로 조정하고 0.45㎛-공극 사이즈 멤브레인 필터로 여과한 후 다음과 같이 실시하였다.The collected supernatant was adjusted to pH 6.5 using 5N NaOH, filtered through a 0.45 μm-pore size membrane filter, and then carried out as follows.

항온 수조 및 오토클레이브(Autoclave)를 이용하여 상등액을 다양한 온도(37, 70, 80, 90, 100, 121℃)로 15분 동안 가열하고 상온으로 냉각시켜 항균활성을 측정한 후 열처리를 하지 않은 대조구와 비교하여 박테리오신 활성의 변화를 조사한 결과, 도 2에서 보는 바와 같이 37, 70, 80, 90 및 100℃로 15분간 열처리한 경우에는 박테리오신의 활성이 소실되지 않고 유지되었으나 121℃에서는 완전히 소실되었다.Controlled supernatant using a constant temperature bath and autoclave for 15 minutes at various temperatures (37, 70, 80, 90, 100, 121 ℃) and cooled to room temperature to measure the antimicrobial activity and then not heat treated As a result of investigating changes in bacteriocin activity, as shown in FIG. 2, when heat treated at 37, 70, 80, 90 and 100 ° C. for 15 minutes, the activity of bacteriocin was maintained without being lost, but completely disappeared at 121 ° C.

따라서, 본 발명의 페디오코쿠스 스피시스 JNU534는 약 100℃ 이하의 온도에서는 소실되지 않는 것을 보여주고 있다.Thus, the Pediococcus spissis JNU534 of the present invention shows that it does not disappear at temperatures below about 100 ° C.

항균효과를 보이는 물질이 단백질성 물질인지 여부를 알아보기 위하여 트립신(Trypsin)(Sigma, USA), 리소자임(lysozyme)(Sigma, USA), 프로테아제(protease)(Sigma, USA)는 50mM Tris-HCl 완충액(pH 7.5), 펩신(pepsin)(Sigma, USA)은 50mM 구연산염(citrate) 완충액(pH 2.0), 프로테이나제 K(proteinase K)(USB, USA)는 10mM Tris-HCl-50mM NaCl-5mM EDTA(pH 7.5)에 각각 용해시켜 효소액을 제조하였다.Trypsin (Sigma, USA), lysozyme (Sigma, USA), and protease (Sigma, USA) are 50 mM Tris-HCl buffers to determine whether the antimicrobial agents are proteinaceous. pH 7.5, pepsin (Sigma, USA) 50 mM citrate buffer (pH 2.0), proteinase K (USB, USA) 10 mM Tris-HCl-50 mM NaCl-5 mM Each was dissolved in EDTA (pH 7.5) to prepare an enzyme solution.

이를 박테리오신 용액에 각각 4mg/ml 농도로 첨가하여 37℃ 항온 수조에서 12시간 동안 반응시킨 후 박테리오신 활성을 측정하였다. 대조구로는 동일한 조건에서 효소액을 처리하지 않은 것을 사용하였다.This was added to the bacteriocin solution at a concentration of 4 mg / ml, respectively, and reacted in a 37 ° C. constant temperature water bath for 12 hours, and then the bacteriocin activity was measured. As a control, one that was not treated with enzyme solution under the same conditions was used.

상기 박테리오신 활성 결과는 도 3에서 보는 바와 같이, 세포벽의 다당류 사슬을 분해하는 효소인 리소자임에 의해서는 박테리오신 활성이 유지되었으나 단백질 가수분해효소인 트립신, 펩신, 프로테아제 및 프로테이나제 K에 의해서는 박테리오신 활성이 제거됨으로써 단백질성 물질임을 확인할 수 있었으므로 보존제로서의 안전성이 매우 높을 것으로 여겨진다.As shown in Figure 3, the bacteriocin activity was maintained by lysozyme, an enzyme that breaks down the polysaccharide chain of the cell wall, but bacteriocin was maintained by proteinases trypsin, pepsin, protease and proteinase K. Since the activity was removed, it was confirmed that it is a proteinaceous material, and thus, the safety as a preservative is considered to be very high.

따라서, 본 발명의 페디오코쿠스 스피시스 JNU534는 리스테리아 모노시토제네스, 리스테리아 모노시토제네스 KCTC 3569, 스타필로코커스 오레우스, 락토바실러스 플란타럼 KCCM 11322, 락토바실러스 플란타럼 L155, 락토바실러스 플란타럼 L165, 락토바실러스 플란타럼 L167, 락토바실러스 애시도필러스 NOCKS, 락토바실러스 애시도필러스 KCCM 32820, 락토바실러스 애시도필러스 CH5, 락토바실러스 애시도필러스 GP1B, 락토바실러스 가세리 KCTC 3163, 락토바실러스 크리스파터스 KCCM 41620, 락토바실러스 브레비스 KCCM 35464, 락토바실러스 카제이 YIT 9029, 락토바실러스 카제이 Y1, 락토바실러스 람노수스 GG 및 류코노스톡 메센테로이데스 KCCM 35471 등과 같은 유해한 미생물과 식품의 변패를 일으키는 미생물의 생육을 억제시키는 항균능력을 가지고 있어 페디오코쿠스 스피시스 JNU534 자체 또는 그 배양물을 천연방부제, 식품 조성물, 사료용 조성물 및 항균 조성물로 이용할 수 있다.Thus, the Pediococcus spissis JNU534 of the present invention is Listeria monocytogenes, Listeria monocytogenes KCTC 3569, Staphylococcus oreus, Lactobacillus plantarum KCCM 11322, Lactobacillus plantarum L155, Lactobacillus plantarum L165, Lactobacillus plantarum L167, Lactobacillus ashdophyllus NOCKS, Lactobacillus ashdophyllus KCCM 32820, Lactobacillus ashdophyllus CH5, Lactobacillus ashdophilus GP1B, Lactobacillus gasseri KCTC 3163, Lactobacillus Harmful microorganisms and foods such as Bacillus crispatus KCCM 41620, Lactobacillus brevis KCCM 35464, Lactobacillus cascai YIT 9029, Lactobacillus cascai Y1, Lactobacillus rhamnosus GG, and leukonostock mesenteroides KCCM 35471 Pediococcus spissis with antibacterial ability to restrain microbial growth JNU534 itself or its culture can be used as a natural preservative, food composition, feed composition and antimicrobial composition.

따라서, 본 발명의 페디오코쿠스 스피시스 JNU534는 병원성 미생물과 부패성 미생물 등의 유해한 미생물의 생육을 억제시키는 항균능력을 가지고 있어 천연방부 제, 식품 조성물, 사료용 조성물 및 항균 조성물으로 이용될 수 있어 산업상에 매우 폭넓게 활용될 수 있는 효과가 있다.Therefore, the Pediococcus spis JNU534 of the present invention has an antimicrobial ability to inhibit the growth of harmful microorganisms, such as pathogenic microorganisms and decaying microorganisms can be used as natural preservatives, food compositions, feed compositions and antimicrobial There is an effect that can be used very widely.

본 발명은 이상에서 살펴본 바와 같이 바람직한 실시 예를 들어 도시하고 설명하였으나, 상기한 실시 예에 한정되지 아니하며 본 발명의 정신을 벗어나지 않는 범위 내에서 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자에 의해 다양한 변경과 수정이 가능할 것이다.Although the present invention has been shown and described with reference to preferred embodiments as described above, it is not limited to the above-described embodiments and those skilled in the art without departing from the spirit of the present invention. Various changes and modifications will be possible.

Claims (9)

김치로부터 분리가능 하고, 유해성 미생물 또는 식품의 변패를 일으키는 미생물의 생육을 억제하는 기능을 가지며, 최초 8개의 아미노산의 서열이 NH2-Ile-Leu-Leu-Glu-Glu-Leu-Asn-Val이고 분자량이 3.4kDa인 박테리오신을 생산하는 페디오코쿠스 스피시스 JNU534(기탁기관 : 한국종균협회부설 한국미생물보존센터, 수탁번호 : KCCM-10869P호, 수탁일자 : 2007년 5월 2일).It is separable from kimchi and has the function of inhibiting the growth of harmful microorganisms or microorganisms causing the deterioration of food, and the sequence of the first 8 amino acids is NH 2 -Ile-Leu-Leu-Glu-Glu-Leu-Asn-Val Pediococcus spissis JNU534, which produces bacteriocin with a molecular weight of 3.4 kDa (depositment institution: Korea Microbiological Conservation Center, affiliated with the Korean spawn association, Accession No .: KCCM-10869P, date of deposit: May 2, 2007). 삭제delete 제 1 항에 있어서,The method of claim 1, 상기 유해성 미생물 또는 식품을 변패를 일으키는 미생물은 리스테리아 모노시토제네스, 리스테리아 모노시토제네스 KCTC 3569, 스타필로코커스 오레우스, 락토바실러스 플란타럼 KCCM 11322, 락토바실러스 플란타럼 L155, 락토바실러스 플란타럼 L165, 락토바실러스 플란타럼 L167, 락토바실러스 애시도필러스 NOCKS, 락토바실러스 애시도필러스 KCCM 32820, 락토바실러스 애시도필러스 CH5, 락토바실러스 애시도필러스 GP1B, 락토바실러스 가세리 KCTC 3163, 락토바실러스 크리스파터스 KCCM 41620, 락토바실러스 브레비스 KCCM 35464, 락토바실러스 카제이 YIT 9029, 락토바실러스 카제이 Y1, 락토바실러스 람노수스 GG 및 류코노스톡 메센테로이데스 KCCM 35471 중 어느 하나 이상인 것을 특징으로 하는 페디오코쿠스 스피시스 JNU534.The harmful microorganisms or microorganisms that cause the food to deteriorate are Listeria monocytogenes, Listeria monocytogenes KCTC 3569, Staphylococcus oreus, Lactobacillus plantarum KCCM 11322, Lactobacillus plantarum L155, Lactobacillus plantarum L165 , Lactobacillus plantarum L167, Lactobacillus ashdophyllus NOCKS, Lactobacillus ashdophilus KCCM 32820, Lactobacillus ashdophyllus CH5, Lactobacillus ashdophilus GP1B, Lactobacillus gaseri KCTC 3163, Lactobacillus Pediococcus, characterized by at least one of Crispaters KCCM 41620, Lactobacillus brevis KCCM 35464, Lactobacillus cassia YIT 9029, Lactobacillus cassia Y1, Lactobacillus ramnosus GG and Leukonostock Mesenteroides KCCM 35471 Spicy JNU534. 삭제delete 삭제delete 제1항의 페디오코쿠스 스피시스 JNU534 또는 그 배양물을 포함하는 것을 특징으로 하는 천연방부제.Pediococcus spissis JNU534 of claim 1 or a natural preservative comprising the culture thereof. 제1항의 페디오코쿠스 스피시스 JNU534 또는 그 배양물을 포함하는 것을 특징으로 하는 식품 조성물.A food composition comprising the pediococcus spissis JNU534 or its culture according to claim 1. 제1항의 페디오코쿠스 스피시스 JNU534 또는 그 배양물을 포함하는 것을 특징으로 하는 사료용 조성물.Pediococcus spissis JNU534 of claim 1 or a composition for a feed comprising a culture thereof. 제1항의 페디오코쿠스 스피시스 JNU534 또는 그 배양물을 포함하는 것을 특징으로 하는 항균 조성물.The antimicrobial composition of Claim 1 containing the pediococcus spisus JNU534 or its culture.
KR1020070060639A 2007-06-20 2007-06-20 Pediococcus spissis JNU44 Active KR100890462B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070060639A KR100890462B1 (en) 2007-06-20 2007-06-20 Pediococcus spissis JNU44

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070060639A KR100890462B1 (en) 2007-06-20 2007-06-20 Pediococcus spissis JNU44

Publications (2)

Publication Number Publication Date
KR20080111990A KR20080111990A (en) 2008-12-24
KR100890462B1 true KR100890462B1 (en) 2009-03-26

Family

ID=40370030

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070060639A Active KR100890462B1 (en) 2007-06-20 2007-06-20 Pediococcus spissis JNU44

Country Status (1)

Country Link
KR (1) KR100890462B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101835809B1 (en) * 2016-02-29 2018-03-12 전남대학교산학협력단 Preparing method for yogurt

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101215422B1 (en) * 2010-04-06 2013-01-09 우리생명과학(주) Pediococcus acidilactici WRL-1 and use of the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929445A (en) * 1988-01-25 1990-05-29 Microlife Technics, Inc. Method for inhibiting Listeria monocytogenes using a bacteriocin
KR20020012171A (en) * 1999-04-09 2002-02-15 부쳐-랄슨 에이. Novel protective cultures and use thereof for preserving foodstuffs
KR20040010415A (en) * 2002-08-14 2004-01-31 주식회사 이롬라이프 Novel Pediococcus pentosaceus EROM101 having immune enhancement, anticancer and antibacterial activities
KR20040080078A (en) * 2003-03-10 2004-09-18 한국식품개발연구원 E.coli O157:H7 Inhibiting Agent Comprising P. acidilactici or/and Bacteriocin and Effective Amount of Lactic Acid, and Preservation Method of Food

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929445A (en) * 1988-01-25 1990-05-29 Microlife Technics, Inc. Method for inhibiting Listeria monocytogenes using a bacteriocin
KR20020012171A (en) * 1999-04-09 2002-02-15 부쳐-랄슨 에이. Novel protective cultures and use thereof for preserving foodstuffs
KR20040010415A (en) * 2002-08-14 2004-01-31 주식회사 이롬라이프 Novel Pediococcus pentosaceus EROM101 having immune enhancement, anticancer and antibacterial activities
KR20040080078A (en) * 2003-03-10 2004-09-18 한국식품개발연구원 E.coli O157:H7 Inhibiting Agent Comprising P. acidilactici or/and Bacteriocin and Effective Amount of Lactic Acid, and Preservation Method of Food

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101835809B1 (en) * 2016-02-29 2018-03-12 전남대학교산학협력단 Preparing method for yogurt

Also Published As

Publication number Publication date
KR20080111990A (en) 2008-12-24

Similar Documents

Publication Publication Date Title
Todorov et al. Bacteriocinogenic Lactobacillus plantarum ST16Pa isolated from papaya (Carica papaya)—From isolation to application: Characterization of a bacteriocin
Janes et al. Identification and characterization of two bacteriocin-producing bacteria isolated from garlic and ginger root
Yildirim et al. Characterization and antimicrobial spectrum of bifidocin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454
JP6709208B2 (en) New Lactobacillus strain and its use
Gonzalez et al. Detection, purification, and partial characterization of plantaricin C, a bacteriocin produced by a Lactobacillus plantarum strain of dairy origin
Abo-Amer Characterization of a bacteriocin-like inhibitory substance produced by Lactobacillus plantarum isolated from Egyptian home-made yogurt
Ahmed et al. Lactobacillus acidophilus bacteriocin, from production to their application: An overview
Pal et al. Isolation and characterization of bacteriocin producing lactic acid bacteria from a South Indian Special dosa (Appam) batter
Bennik et al. Vegetable-associated Pediococcus parvulus produces pediocin PA-1
EP2592158A1 (en) Lactobacillus plantarum species possessing broad spectrum anti-fungal activity and exhibiting high heat tolerance and osmotolerance
Şahingil et al. Characterization of lactococcin BZ produced by Lactococcus lactis subsp. lactis BZ isolated from boza
US5908646A (en) Inhibition of clostridia with lactic acid bacteria
Olasupo et al. Bacteriocin production by Enterococcus faecium NA01 from ‘wara’—a fermented skimmed cow milk product from West Africa
Kato et al. Complete growth inhibition of Bacillus subtilis by nisin-producing lactococci in fermented soybeans
KR100890462B1 (en) Pediococcus spissis JNU44
KR20050106022A (en) Control of enzymatic degradation of glucosinolates by lactic acid bacterium
Hemme Leuconostoc and its use in dairy technology
KR101302465B1 (en) Lactic acid bacterium separated from kimchii and fermented food using the strain
US20040208978A1 (en) Novel lactic acid bacteria and bacteriocins produced therefrom, and method for processing fish and legume foodstuffs using the same and the products obtained thereby
Aslam et al. Production optimization and characterization of a low molecular weight bacteriocin from Lactococcus lactis subsp. lactis
Mojgani et al. Characterization of bacteriocins produced by Lactobacillus brevis NM 24 and L. fermentum NM 332 isolated from green olives in Iran
KR100528641B1 (en) Leuconostoc citreum gj7 and bacteriocin produced from same
Zamfir et al. Impact of stress conditions on the growth of Lactobacillus acidophilus IBB 801 and production of acidophilin 801
Kawahara et al. Characterization of multiple bacteriocin-producing Lactiplantibacillus plantarum PUK6 isolated from misozuke-tofu
KR100509558B1 (en) Lactobacillus plantarum j9 and use thereof

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20070620

PA0201 Request for examination
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080922

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20081216

PG1501 Laying open of application
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20090318

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20090319

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20120319

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20130201

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20130201

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20140203

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20140203

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20150130

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20150130

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20160316

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20160316

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20170118

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20170118

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20180209

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20180209

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20200219

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20200219

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20210302

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20230201

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20240205

Start annual number: 16

End annual number: 16

PR1001 Payment of annual fee

Payment date: 20250318

Start annual number: 17

End annual number: 17